vs
Doximity, Inc.（DOCS）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
Tilray Brands, Inc.的季度营收约是Doximity, Inc.的1.2倍（$217.5M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs -20.7%，领先53.9%），Doximity, Inc.同比增速更快（9.8% vs 3.1%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs 7.5%）
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
DOCS vs TLRY — 直观对比
营收规模更大
TLRY
是对方的1.2倍
$185.1M
营收增速更快
DOCS
高出6.6%
3.1%
净利率更高
DOCS
高出53.9%
-20.7%
两年增速更快
DOCS
近两年复合增速
7.5%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $217.5M |
| 净利润 | $61.6M | $-44.9M |
| 毛利率 | 89.9% | 26.4% |
| 营业利润率 | 38.9% | -10.2% |
| 净利率 | 33.3% | -20.7% |
| 营收同比 | 9.8% | 3.1% |
| 净利润同比 | -18.1% | 47.4% |
| 每股收益（稀释后） | $0.31 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSTLRY
| Q4 25 | $185.1M | $217.5M | ||
| Q3 25 | $168.5M | $209.5M | ||
| Q2 25 | $145.9M | $224.5M | ||
| Q1 25 | $138.3M | $185.8M | ||
| Q4 24 | $168.6M | $210.9M | ||
| Q3 24 | $136.8M | $200.0M | ||
| Q2 24 | $126.7M | $229.9M | ||
| Q1 24 | $118.1M | $188.3M |
净利润DOCSTLRY
| Q4 25 | $61.6M | $-44.9M | ||
| Q3 25 | $62.1M | $-322.0K | ||
| Q2 25 | $53.3M | $-1.3B | ||
| Q1 25 | $62.5M | $-789.4M | ||
| Q4 24 | $75.2M | $-85.3M | ||
| Q3 24 | $44.2M | $-39.2M | ||
| Q2 24 | $41.4M | $-31.7M | ||
| Q1 24 | $40.6M | $-92.7M |
毛利率DOCSTLRY
| Q4 25 | 89.9% | 26.4% | ||
| Q3 25 | 90.3% | 27.4% | ||
| Q2 25 | 89.2% | 30.1% | ||
| Q1 25 | 89.5% | 28.0% | ||
| Q4 24 | 91.6% | 29.0% | ||
| Q3 24 | 90.0% | 29.8% | ||
| Q2 24 | 89.3% | 35.8% | ||
| Q1 24 | 89.4% | 26.2% |
营业利润率DOCSTLRY
| Q4 25 | 38.9% | -10.2% | ||
| Q3 25 | 37.8% | 1.0% | ||
| Q2 25 | 37.4% | -643.1% | ||
| Q1 25 | 35.2% | -409.0% | ||
| Q4 24 | 47.4% | -20.0% | ||
| Q3 24 | 38.8% | -18.3% | ||
| Q2 24 | 36.4% | -7.2% | ||
| Q1 24 | 35.5% | -43.6% |
净利率DOCSTLRY
| Q4 25 | 33.3% | -20.7% | ||
| Q3 25 | 36.8% | -0.2% | ||
| Q2 25 | 36.5% | -566.9% | ||
| Q1 25 | 45.2% | -424.9% | ||
| Q4 24 | 44.6% | -40.5% | ||
| Q3 24 | 32.3% | -19.6% | ||
| Q2 24 | 32.7% | -13.8% | ||
| Q1 24 | 34.4% | -49.2% |
每股收益（稀释后）DOCSTLRY
| Q4 25 | $0.31 | $-0.41 | ||
| Q3 25 | $0.31 | $0.00 | ||
| Q2 25 | $0.27 | $7.26 | ||
| Q1 25 | $0.31 | $-8.69 | ||
| Q4 24 | $0.37 | $-0.99 | ||
| Q3 24 | $0.22 | $-0.04 | ||
| Q2 24 | $0.21 | $-0.04 | ||
| Q1 24 | $0.20 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $979.3M | $1.6B |
| 总资产 | $1.2B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCSTLRY
| Q4 25 | $64.8M | $291.6M | ||
| Q3 25 | $169.2M | $264.8M | ||
| Q2 25 | $137.3M | $256.4M | ||
| Q1 25 | $209.6M | — | ||
| Q4 24 | $165.3M | $252.2M | ||
| Q3 24 | $184.2M | $280.1M | ||
| Q2 24 | $111.4M | $260.5M | ||
| Q1 24 | $96.8M | $225.9M |
股东权益DOCSTLRY
| Q4 25 | $979.3M | $1.6B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $1.1B | $2.7B | ||
| Q4 24 | $1.0B | $3.5B | ||
| Q3 24 | $961.2M | $3.5B | ||
| Q2 24 | $913.6M | $3.4B | ||
| Q1 24 | $901.4M | $3.4B |
总资产DOCSTLRY
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.2B | $4.2B | ||
| Q3 24 | $1.1B | $4.3B | ||
| Q2 24 | $1.1B | $4.2B | ||
| Q1 24 | $1.1B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCSTLRY
| Q4 25 | $60.9M | $-8.5M | ||
| Q3 25 | $93.9M | $-1.3M | ||
| Q2 25 | $62.1M | $-12.8M | ||
| Q1 25 | $98.5M | $-5.8M | ||
| Q4 24 | $65.2M | $-40.7M | ||
| Q3 24 | $68.3M | $-35.3M | ||
| Q2 24 | $41.2M | $30.7M | ||
| Q1 24 | $63.9M | $-15.4M |
自由现金流DOCSTLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-19.1M | ||
| Q1 25 | — | $-20.2M | ||
| Q4 24 | — | $-46.2M | ||
| Q3 24 | — | $-42.0M | ||
| Q2 24 | — | $21.0M | ||
| Q1 24 | — | $-24.9M |
自由现金流率DOCSTLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -8.5% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | -21.9% | ||
| Q3 24 | — | -21.0% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | — | -13.2% |
资本支出强度DOCSTLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | 0.0% | 7.8% | ||
| Q4 24 | 0.0% | 2.6% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | 0.0% | 4.2% | ||
| Q1 24 | 0.0% | 5.1% |
现金转化率DOCSTLRY
| Q4 25 | 0.99× | — | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.58× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 1.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
